Chemomab Therapeutics (CMMB) Change in Taxes (2018)

Chemomab Therapeutics (CMMB) posted Change in Taxes of $160000.0 for Q4 2018, up 135.29% on a QoQ basis from $68000.0 in Q3 2018.

Chemomab Therapeutics (CMMB) Change in Taxes (2018) Analysis & Trends

Chemomab Therapeutics' Change in Taxes history runs 1 years deep, the most recent figure standing at $160000.0 for Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Taxes (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-8,939.03
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	-
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Chemomab Therapeutics	704.11 Mn	693.75 Mn	-	-

Download Data